SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IPIC
IPIC 0.00010000.0%Dec 18 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ernie de la fuente who wrote (781)10/8/1997 10:00:00 PM
From: WeirdPro Randy   of 1359
 
PMS Escape will not be a cure, but will help ease some pain....after a trial in New England area bringing in about 1 million dollars, national distribution is being ramped up on the heels of the Redux recall........good idea as it gives the 35 person sales force something to do in the meantime.
Meanwhile, it is expected that citicoline will be put on the "fast-track" with their NDA......meaning it easily could hit the market by mid-spring.........and although the salesforce may be targeting the OB-GYN offices for PMS Escape, they may have time to stop by the local neurologists offices and the ER's also to shoot the breeze.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News